openPR Logo

Press Releases from Lnx Pharma (2 total)

Lnx Pharma to present “Six-Degrees of Separation in Understanding the Business …

Nov. 1, 2009 (ORANGE, CA) – Philip Topham, General Manager of cutting-edge research firm Lnx Pharma, will present on the topic of advanced Key Opinion Leader development tactics for distinguished colleagues at a medical and pharmaceutical industry conference “Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders (KOLs),” hosted by The Center for Business Intelligence, on November 9-10, 2009, in Princeton, NJ. Mr. Topham’s session is entitled “Six-Degrees

In Key Opinion Leader Management, Quantity Does Not Equal Quality in Evaluating …

Using Social Network Analysis in Influence Mapping, Lnx Pharma Research Finds Pharmaceutical Companies May Be Ignoring Up To 50% of Key Scientific Leaders ORANGE, CA -- September 30, 2009 -- Lnx Pharma's research results shatter current best practice for companies in pharmaceutical and biotechnology research who seek out "Key Opinion Leaders" (KOLs) among the scientific community to help advise research and development teams. In drug development and pharmaceutical market research, companies seek

Go To Page:   1 2 3 4 5 6 7 8 9 10